Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Dercle

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Diagnostics (Basel, Switzerland)|August 7, 2021
Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with BevacizumabSamy Ammari, Raoul Sallé de Chou, Tarek Assi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 25, 2016
Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapyLaurent Dercle, Samy Ammari, Stéphane Champiat, et al.
Clinical Nuclear Medicine|July 11, 2025
Comparison of MRI, [18F]FDG-PET/CT, and [18F]FDG-PET/MRI for Initial Staging of Multiple Myeloma: A Systematic Review and Meta-analysisMickael Tordjman, Murat Yuce, Amine Geahchan, et al.
Frontiers in Oncology|February 8, 2021
Influence of Magnetic Field Strength on Magnetic Resonance Imaging Radiomics Features in Brain Imaging, an <i>In Vitro</i> and <i>In Vivo</i> StudySamy Ammari, Stephanie Pitre-Champagnat, Laurent Dercle, et al.
European Journal of Radiology|November 30, 2019
Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approachLaura Rozenblum, Fatima-Zohra Mokrane, Randy Yeh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 27, 2019
Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomicsRomain-David Seban, John S Nemer, Aurélien Marabelle, et al.
JAMA Oncology|January 20, 2022
Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging AnalysisLaurent Dercle, Binsheng Zhao, Mithat Gönen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2022
High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapyLaurent Dercle, Samy Ammari, Elvire Roblin, et al.
Journal of Clinical Medicine|August 12, 2023
PET/CT and SPECT/CT Imaging of HER2-Positive Breast CancerJeremy McGale, Sakshi Khurana, Alice Huang, et al.
Journal of Clinical Medicine|July 14, 2023
Advances in PET/CT Imaging for Breast CancerDorine de Jong, Elise Desperito, Karine A Al Feghali, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Diagnostics (Basel, Switzerland)|August 7, 2021
Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with BevacizumabSamy Ammari, Raoul Sallé de Chou, Tarek Assi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 25, 2016
Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapyLaurent Dercle, Samy Ammari, Stéphane Champiat, et al.
Clinical Nuclear Medicine|July 11, 2025
Comparison of MRI, [18F]FDG-PET/CT, and [18F]FDG-PET/MRI for Initial Staging of Multiple Myeloma: A Systematic Review and Meta-analysisMickael Tordjman, Murat Yuce, Amine Geahchan, et al.
Frontiers in Oncology|February 8, 2021
Influence of Magnetic Field Strength on Magnetic Resonance Imaging Radiomics Features in Brain Imaging, an <i>In Vitro</i> and <i>In Vivo</i> StudySamy Ammari, Stephanie Pitre-Champagnat, Laurent Dercle, et al.
European Journal of Radiology|November 30, 2019
Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approachLaura Rozenblum, Fatima-Zohra Mokrane, Randy Yeh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 27, 2019
Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomicsRomain-David Seban, John S Nemer, Aurélien Marabelle, et al.
JAMA Oncology|January 20, 2022
Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging AnalysisLaurent Dercle, Binsheng Zhao, Mithat Gönen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2022
High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapyLaurent Dercle, Samy Ammari, Elvire Roblin, et al.
Journal of Clinical Medicine|August 12, 2023
PET/CT and SPECT/CT Imaging of HER2-Positive Breast CancerJeremy McGale, Sakshi Khurana, Alice Huang, et al.
Journal of Clinical Medicine|July 14, 2023
Advances in PET/CT Imaging for Breast CancerDorine de Jong, Elise Desperito, Karine A Al Feghali, et al.
Pageof 14